EPIC Self-Expanding Stent System
Boston Scientific Corp · Decision date Apr 2, 2026
What did the FDA decide?
FDA records P110035/S075 as a supplement to PMA P110035, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 2, 2026.
FDA approval order statement
a replacement vision system for stent visual inspections, changes to the stent inspection flow and level of inspections
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Apr 2, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P110035/S075
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific Corp
- Product code
- NIO
- Decision code
- OK30
- Decision date
- Apr 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, ILIAC.
- Applicant
- Boston Scientific Corp
- Product code
- NIO
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P110035/S074 · Related supplement
Epic Vascular Self-Expanding Stent System
P110035/S075 received
Application receipt date recorded by FDA.
P110035/S075 · FDA decision
30-Day Notice
P110035/S076 · Related supplement
Epic Vascular Self-Expanding Stent System
P110035/S078 · Related supplement
Epic Vascular Self-Expanding Stent System
P110035/S079 · Related supplement
Epic Vascular Self-Expanding Stent System
Timeline entries are records held by MedtechLedger for P110035. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P110035
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Epic Vascular Self-Expanding Stent SystemP110035/S074 | Boston Scientific Corp | PMA supplement | Aug 8, 2025 | FDA |
Epic Vascular Self-Expanding Stent SystemP110035/S076 | Boston Scientific Corp | PMA supplement | May 6, 2026 | FDA |
Epic Vascular Self-Expanding Stent SystemP110035/S078 | Boston Scientific Corp | PMA supplement | Aug 6, 2026 | FDA |
Epic Vascular Self-Expanding Stent SystemP110035/S079 | Boston Scientific Corp | PMA supplement | Aug 21, 2026 | FDA |
Explore the linked device profile
Other records with product code NIO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook Ireland, Ltd. | PMA supplement | Nov 6, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
S.M.A.R.T. CONTROL Nitinol Stent SystemP020036/S061 | Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA |
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA | |
MISAGO(TM) RX Self-expanding Peripheral StentP140002/S032 | Terumo Medical Corporation | PMA supplement | Jul 16, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific Corp
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- Ballybrit Industrial Estate,Ballybrit, Galway, H91 Y868
Sources and methodology
- Original FDA record: P110035/S075
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





